Annual report pursuant to Section 13 and 15(d)

9. STOCK OPTIONS (Details 1)

v3.3.1.900
9. STOCK OPTIONS (Details 1) - USD ($)
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Stock-based compensation expenses    
Total stock-based compensation expense $ 1,711,047 $ 1,248,454
Research and Development Expense    
Stock-based compensation expenses    
Total stock-based compensation expense 724,776 541,140
Plasma centers [Member]    
Stock-based compensation expenses    
Total stock-based compensation expense 48,386 56,900
General and Administrative Expense    
Stock-based compensation expenses    
Total stock-based compensation expense $ 937,885 $ 650,414